Viome Vs Zoe

Viome and Zoe both sell personalized nutrition, and both hand you food scores at the end. They arrive at those scores from opposite directions. Viome sequences the RNA in a single stool sample and infers recommendations from which microbes are active. Zoe measures your own glucose and blood fat response to food across two weeks, alongside a microbiome sample and daily food logs, and scores from what your body actually did. The choice comes down to which signal you find more convincing and how much measurement you will genuinely complete.

What each platform actually is

Viome

Viome sells a mail-in test. You collect a stool sample at home, post it back, and the lab sequences the RNA from the microbes in it — metatranscriptomics, which captures which organisms are actively transcribing rather than only which are present. The output is a report: personalized food scores across thousands of foods sorted into Superfoods, Enjoy, Minimize and Avoid, plus scores on integrative measures such as gut microbial health, digestive efficiency, and inflammatory activity. Higher tiers add oral, cellular, and biological age measures from separate assays. Viome also sells supplement subscriptions formulated from your results, priced separately. It is not a clinical diagnostic and there is no clinician attached to the product.

Zoe

Zoe sells a two-week measurement program with an app on the other side. The kit contains four components: a stool microbiome test using DNA sequencing, a continuous glucose monitor worn for two weeks, a blood fat response test built around a standardized meal, and a food-logging requirement covering every meal in that window. From the combined data it produces food scores reflecting how your metabolism handled real meals, then keeps scoring meals through an ongoing membership app. The scoring methodology builds on the PREDICT studies, published in peer-reviewed journals including Nature Medicine. Like Viome, Zoe is a nutrition program rather than a diagnostic, and no clinician reviews your data.

Side by side

The same attributes applied to both products. They separate most on what is measured, how much of your time it takes, and what the scores are ultimately derived from.

What each actually costs

Viome is priced as a purchase, not a subscription. The test runs $149–$399 depending on tier, and that buys the report outright — there is no membership standing between you and your results. The recurring cost is optional but real in practice: Viome recommends annual retesting because microbiome composition shifts, so an engaged user pays the test price again each year. Supplements formulated from your results are sold separately and are where ongoing spend typically accumulates. A second year without a retest and without supplements costs nothing at all.

Zoe inverts that structure. The kit is around $300 once, and it covers the CGM, the microbiome sample, and the blood fat test — the whole measurement layer, paid for one time. The membership is what recurs, and it is where the scoring app lives, so the ongoing fee is not an add-on but the working part of the product. Because there is no routine retest, year two is membership alone and the $300 does not repeat. Membership pricing varies by region and plan, which makes a single quotable annual figure harder to state.

Where Viome leads

• Low engagement. One stool sample and one report. No wearable, no logging window, and nothing to keep up with after collection.
• Metatranscriptomics. RNA sequencing captures which microbes are actively transcribing, a functional signal that DNA-only sequencing does not produce.
• Broader integrative scores at the top tier. Full Body Intelligence adds oral, cellular, and biological age measures drawn from separate assays.
• No subscription to read your results. The purchase price buys the report permanently; any further spend is a choice you make later.
• Lower entry point. The $149 tier is the cheapest way into personalized food scoring across these two products.

Where Zoe leads

• Measured metabolic response. Glucose and blood fat data record what your body did with food, rather than what a microbial profile suggests it might do.
• Published evidence base. The PREDICT studies underpinning the scoring are peer-reviewed and appear in journals including Nature Medicine.
• Ongoing scoring layer. The app continues scoring meals after the two-week window closes, so the product persists past the report.
• Two weeks of continuous glucose data. Set the food scores aside and a 14-day glucose trace still shows post-meal patterns no single blood draw captures.
• Scores tied to your real meals. Because logging runs during measurement, the output maps onto food you actually ate rather than a generic catalogue.

Trade-offs to weigh

Viome trade-offs

• Proprietary scoring. The food-score algorithm is not published and independent validation is limited, so the reasoning behind any individual score cannot be checked.
• Contradictions with standard advice. Foods with strong nutritional consensus sometimes score poorly for an individual. That can be genuinely correct or an artifact of the scoring, and the report does not let you tell which.
• Retesting resets the cost. There is no reduced retest price — a second look means paying $149–$399 again for a full test.
• Not a diagnostic. It does not substitute for a physician-ordered clinical stool test where symptoms point at SIBO, IBS, IBD, or infection.

Zoe trade-offs

• High engagement cost. Two weeks of CGM wear plus daily food logging is a genuine time commitment, and the output degrades for anyone who does not complete it.
• The value sits behind a subscription. The scoring app is the product past the initial report, and it requires an ongoing membership to use.
• Regional variation. Pricing and availability still differ by region, so what a program costs depends partly on where you live.
• Not a diagnostic. As with Viome, it is a nutrition program and not a substitute for clinical workup when GI symptoms suggest pathology.

Who should pick each

Pick Viome if: you want a single purchase with a defined endpoint and no ongoing obligation. You are curious about your microbiome, you will not wear a sensor or log meals for two weeks, and you would rather have a report to read than a protocol to follow. You are comfortable treating food scores as directional. Budget around $149–$399 once, with an annual retest optional rather than assumed.

Pick Zoe if: you will actually complete a two-week measurement window and want scores derived from your own glucose and blood fat responses. You want an app that keeps working after the test, you value a published evidence base over a proprietary one, and you accept that the useful part is subscription-gated. Budget around $300 up front plus a membership that continues for as long as you use it.

Who should pick neither

Both products answer a question about food. Neither answers a question about disease, and neither involves a clinician looking at your case. If your reason for searching is symptoms rather than curiosity — persistent pain, bloating that is worsening, blood, unexplained weight loss — a food-scoring report is the wrong purchase and can delay the right one. Cost is the second filter: a few hundred dollars spent on scoring is money not spent on a dietitian who can work with what the scores would have told you anyway.

• A physician-ordered clinical stool test, or a gastroenterology referral. This is the correct route for symptoms, and it is often covered by insurance in a way direct-to-consumer testing is not.
• Are gut health tests accurate? covers where the measurement is solid, where the advice built on top of it outruns the evidence, and what that means before you buy either of these.
• A registered dietitian. For most people the binding constraint is not knowing which foods score well, but changing what they eat week to week — a dietitian works on that directly and no test is required.
• Levels and Nutrisense — listed alphabetically. If continuous glucose data is the part you actually want, a dedicated CGM program delivers it without the microbiome layer.
• Best gut health test — the wider field, including options built for different questions than these two answer.

Can you use both?

Running both duplicates the microbiome step and produces two answers you have to reconcile without help. Viome sequences RNA, Zoe sequences DNA, and both then output food scores for overlapping foods — from different data, by different algorithms, with no shared standard for resolving a disagreement. When a food is a Superfood on one and a low scorer on the other, neither product explains the other's reasoning, and you are left arbitrating between two proprietary outputs. Combined year-one cost lands roughly between $450 and $700 before Zoe's membership.

The one situation where running both is defensible is sequential and purpose-driven: someone who completed Zoe's two-week window, changed their eating on the strength of it, and then wants to see whether their microbial activity shifted in response. That is a specific before-and-after question Viome's report can speak to and Zoe's does not attempt. Outside that, pick the methodology you find more convincing and put the second product's price toward acting on the first one's results — the recommendations only pay off if you change what you eat.

What the rubric does not capture

A comparison table cannot show what happens in the two weeks Zoe's whole output depends on. The scoring calibrates on the meals you logged, which means an unrepresentative fortnight produces an unrepresentative model. Travel, illness, a holiday, or eating carefully because you know you are being watched all bend the data. This is the most common way the product underdelivers, and it is entirely under your control: run the measurement window on an ordinary two weeks of ordinary food, not a good two weeks. Viome has a smaller version of the same problem — one sample, one moment — with the added wrinkle that a recent course of antibiotics reshapes the microbiome, so a report taken shortly after one is describing a transient state.

Neither table row covers who these products suit poorly. Both sort foods into approved and disapproved categories, and for anyone with a history of disordered eating, that framing is a real risk rather than a neutral feature. Anyone pregnant, breastfeeding, or on a medically supervised diet should treat both as inputs to a clinician's advice rather than instructions, because neither product knows anything about your medical history. A CGM in someone without diabetes also shows glucose swings that are normal physiology, and reading those swings as problems is a failure mode of the format, not of the platform.

Month six is where the two diverge most and where no attribute row helps. Viome by then is a document you either acted on or did not; there is nothing prompting you and nothing recurring, which suits some people and means others never look at it again. Zoe by then is a subscription you are still paying, and its worth depends on whether you still open the app to score meals. The real test for either is not which methodology is better in principle but which format you will still be using six months from purchase — and that is a question about your habits, not about the science.

Related

• Full Viome review
• Full Zoe review
• Best gut health test
• CGM guides — what continuous glucose data does and does not tell you
• Nutrition guides